Pancreatic Cancer Research

ResearcherNational Medical Products AdministrationActive in the last 2 years

Xiaoxia Xu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5113243619. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. KRAS Mutation Detection with (2S,4R)-4-[18F]FGln for Noninvasive PDAC Diagnosis. Last author DOI 10.1021/acs.molpharmaceut.4c00082↗
  2. Clinical Translation of a 68Ga-Labeled Integrin αvβ6-Targeting Cyclic Radiotracer for PET Imaging of Pancreatic Cancer. Co-author DOI 10.2967/jnumed.119.237347↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hua Zhu · 2 shared papers, 2020–2024 · strength 0.33
  2. Zhi Yang · 1 shared paper, 2024 · strength 0.23
  3. Song Liu · 1 shared paper, 2024 · strength 0.23
  4. Zhaofei Liu · 1 shared paper, 2020 · strength 0.10
  5. Xun Feng · 1 shared paper, 2020 · strength 0.10
  6. Fan Wang · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.